Amedisys, Inc. (NASDAQ:AMED - Get Free Report)'s share price gapped up prior to trading on Friday . The stock had previously closed at $85.95, but opened at $89.50. Amedisys shares last traded at $89.46, with a volume of 536,164 shares.
Amedisys Stock Performance
The firm's 50-day simple moving average is $90.45 and its two-hundred day simple moving average is $94.43. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.95 billion, a PE ratio of 35.70, a PEG ratio of 1.84 and a beta of 0.73.
Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 EPS. On average, equities research analysts expect that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Amedisys
A number of large investors have recently made changes to their positions in AMED. KBC Group NV purchased a new position in Amedisys during the third quarter valued at approximately $63,000. Innealta Capital LLC acquired a new position in shares of Amedisys in the second quarter worth $64,000. Signaturefd LLC increased its stake in shares of Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock worth $104,000 after acquiring an additional 530 shares during the last quarter. CWM LLC raised its holdings in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider's stock worth $211,000 after acquiring an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. acquired a new stake in Amedisys during the third quarter valued at $243,000. Institutional investors and hedge funds own 94.36% of the company's stock.
Amedisys Company Profile
(
Get Free Report)
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Featured Articles
Before you consider Amedisys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.
While Amedisys currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
